Elanco Animal Health Incorporated (ELAN)

USD 11.73

(-4.71%)

Operating Income Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual operating income in 2023 was 326 Million USD , down -8.94% from previous year.
Elanco Animal Health Incorporated's latest quarterly operating income in 2024 Q2 was 115 Million USD , down -13.53% from previous quarter.
Elanco Animal Health Incorporated reported an annual operating income of 358 Million USD in 2022, up 20.54% from previous year.
Elanco Animal Health Incorporated reported an annual operating income of 297 Million USD in 2021, up 192.61% from previous year.
Elanco Animal Health Incorporated reported a quarterly operating income of 115 Million USD for 2024 Q2, down -13.53% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly operating income of 53 Million USD for 2023 Q2, down -75.0% from previous quarter.

Annual Operating Income Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual Operating Income of Elanco Animal Health Incorporated (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	326 Million USD	-8.94%
2022	358 Million USD	20.54%
2021	297 Million USD	192.61%
2020	101.5 Million USD	-70.37%
2019	342.6 Million USD	9.18%
2018	313.8 Million USD	120.37%
2017	142.4 Million USD	-49.72%
2016	283.2 Million USD	5144.44%
2015	5.4 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	133 Million USD	654.17%
2024 Q2	115 Million USD	-13.53%
2023 Q2	53 Million USD	-75.0%
2023 Q4	-24 Million USD	-157.14%
2023 FY	326 Million USD	-8.94%
2023 Q3	42 Million USD	-20.75%
2023 Q1	212 Million USD	3433.33%
2022 Q4	6 Million USD	-86.36%
2022 FY	358 Million USD	20.54%
2022 Q3	44 Million USD	-67.41%
2022 Q2	135 Million USD	-20.12%
2022 Q1	169 Million USD	356.06%
2021 Q3	52 Million USD	-56.67%
2021 FY	297 Million USD	192.61%
2021 Q4	-66 Million USD	-226.92%
2021 Q1	89 Million USD	183.18%
2021 Q2	120 Million USD	34.83%
2020 Q3	-13.6 Million USD	-170.83%
2020 Q4	-107 Million USD	-686.76%
2020 FY	101.5 Million USD	-70.37%
2020 Q1	24.6 Million USD	-65.98%
2020 Q2	19.2 Million USD	-21.95%
2019 Q4	72.3 Million USD	-26.22%
2019 Q3	98 Million USD	-8.07%
2019 Q2	106.6 Million USD	14.5%
2019 FY	342.6 Million USD	9.18%
2019 Q1	93.1 Million USD	2.87%
2018 Q4	90.5 Million USD	-13.56%
2018 FY	313.8 Million USD	120.37%
2018 Q3	104.7 Million USD	184.51%
2018 Q2	36.8 Million USD	-55.01%
2018 Q1	81.8 Million USD	169.97%
2017 Q1	62.85 Million USD	0.0%
2017 Q4	30.3 Million USD	138.58%
2017 Q2	62.85 Million USD	0.0%
2017 Q3	12.7 Million USD	-79.79%
2017 FY	142.4 Million USD	-49.72%
2016 FY	283.2 Million USD	5144.44%
2015 FY	5.4 Million USD	0.0%

Peer Operating Income Comparison of Elanco Animal Health Incorporated

Name	Operating Income	Operating Income Difference
Amneal Pharmaceuticals, Inc.	204.37 Million USD	-59.511%
Bausch Health Companies Inc.	963 Million USD	66.147%
Catalent, Inc.	-749 Million USD	143.525%
Emergent BioSolutions Inc.	-726.4 Million USD	144.879%
Perrigo Company plc	151.9 Million USD	-114.615%
Teva Pharmaceutical Industries Limited	433 Million USD	24.711%
Zoetis Inc.	3.06 Billion USD	89.378%